190 related articles for article (PubMed ID: 683632)
1. Amniotic fluid transfer of meperidine from maternal plasma in early pregnancy.
Szeto HH; Zervoudakis IA; Cederqvist LL; Inturrisi CE
Obstet Gynecol; 1978 Jul; 52(1):59-62. PubMed ID: 683632
[TBL] [Abstract][Full Text] [Related]
2. Brain uptake of meperidine in the fetal lamb.
Szeto HH; Clapp JF; Abrams R; Inturrisi CE; Kaiko RF; Larrow RW; Mann LI
Am J Obstet Gynecol; 1980 Nov; 138(5):582-33. PubMed ID: 7425023
[TBL] [Abstract][Full Text] [Related]
3. Increasing amniotic fluid magnesium concentrations with stable maternal serum levels: a prospective clinical trial.
Gortzak-Uzan L; Mezad D; Smolin A; Friger M; Huleihel M; Hallak M
J Reprod Med; 2005 Nov; 50(11):817-20. PubMed ID: 16419627
[TBL] [Abstract][Full Text] [Related]
4. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
Mandelbrot L; Peytavin G; Firtion G; Farinotti R
Am J Obstet Gynecol; 2001 Jan; 184(2):153-8. PubMed ID: 11174495
[TBL] [Abstract][Full Text] [Related]
5. The feto-maternal distribution of diazepam in early human pregnancy.
Kanto J; Erkkola R
Ann Chir Gynaecol Fenn; 1974; 63(6):489-91. PubMed ID: 4441031
[TBL] [Abstract][Full Text] [Related]
6. Studies of maternal plasma prolactin and amniotic fluid prolactin. Effects of chlorpromazine and prostaglandin F2alpha.
Freeman R; Lev-Gur M; Boyar RM; Schulman H
Obstet Gynecol; 1976 Mar; 47(3):282-6. PubMed ID: 2892
[TBL] [Abstract][Full Text] [Related]
7. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
[TBL] [Abstract][Full Text] [Related]
8. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid.
Mihailović M; Cvetković M; Ljubić A; Kosanović M; Nedeljković S; Jovanović I; Pesut O
Biol Trace Elem Res; 2000 Jan; 73(1):47-54. PubMed ID: 10949968
[TBL] [Abstract][Full Text] [Related]
9. In vivo maternal-fetal-amniotic fluid pharmacokinetics of zidovudine in the pigtailed macaque: comparison of steady-state and single-dose regimens.
Tuntland T; Odinecs A; Nosbisch C; Unadkat JD
J Pharmacol Exp Ther; 1998 Apr; 285(1):54-62. PubMed ID: 9535994
[TBL] [Abstract][Full Text] [Related]
10. Meperidine pharmacokinetics in the maternal-fetal unit.
Szeto HH; Mann LI; Bhakthavathsalan A; Liu M; Inturrisi CE
J Pharmacol Exp Ther; 1978 Aug; 206(2):448-59. PubMed ID: 682125
[No Abstract] [Full Text] [Related]
11. Ontogeny of foetal exposure to maternal cortisol using midtrimester amniotic fluid as a biomarker.
Sarkar P; Bergman K; Fisk NM; O'Connor TG; Glover V
Clin Endocrinol (Oxf); 2007 May; 66(5):636-40. PubMed ID: 17492950
[TBL] [Abstract][Full Text] [Related]
12. Progesterone levels in amniotic fluid and maternal plasma in prostaglandin F2alpha-induced midtrimester abortion.
Koren Z; Schulman H; Lev-Gur M; Gatz M; Thysen B; Bloch E
Obstet Gynecol; 1976 Oct; 48(4):427-4. PubMed ID: 967379
[TBL] [Abstract][Full Text] [Related]
13. Placental transfer of thiamphenicol.
Plomp TA; Maes RA; Thiery M; Yo Le Sian A
Z Geburtshilfe Perinatol; 1976 Apr; 180(2):149-56. PubMed ID: 936712
[TBL] [Abstract][Full Text] [Related]
14. Disposition of meperidine and normeperidine following multiple doses during labor. I. Mother.
Kuhnert BR; Philipson EH; Kuhnert PM; Syracuse CD
Am J Obstet Gynecol; 1985 Feb; 151(3):406-9. PubMed ID: 3970109
[TBL] [Abstract][Full Text] [Related]
15. Meperidine metabolism in the parturient.
Morrison JC; Todd EL; Lipshitz J; Anderson GD; Schneider JM; Dilts PV
Obstet Gynecol; 1982 Mar; 59(3):359-65. PubMed ID: 7200592
[TBL] [Abstract][Full Text] [Related]
16. Placental transfer and metabolism of betamethasone in human pregnancy.
Anderson AB; Gennser G; Jeremy JY; Ohrlander S; Sayers L; Turnbull AC
Obstet Gynecol; 1977 Apr; 49(4):471-4. PubMed ID: 857211
[TBL] [Abstract][Full Text] [Related]
17. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
18. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
[TBL] [Abstract][Full Text] [Related]
19. Elevated amniotic fluid leptin levels in early second trimester are associated with earlier delivery and lower birthweight in twin pregnancy.
Chan TF; Chung YF; Chen HS; Su JH; Yuan SS
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):707-10. PubMed ID: 15255841
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of meperidine and normeperidine in biofluids.
Szeto HH; Inturrisi CE
J Chromatogr; 1976 Oct; 125(3):503-10. PubMed ID: 993288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
